IMDX
Insight Molecular Diagnostics
IMDX
IMDX
59 hedge funds and large institutions have $43.4M invested in Insight Molecular Diagnostics in 2020 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 26 increasing their positions, 14 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
44% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 16
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
59
Holding in Top 10
1
Calls
$20K
Puts
–
Top Buyers
| 1 | +$966K | |
| 2 | +$279K | |
| 3 | +$239K | |
| 4 |
Goldman Sachs
New York
|
+$197K |
| 5 |
Bank Julius Baer & Co
Zurich,
Switzerland
|
+$167K |
Top Sellers
| 1 | -$5.7M | |
| 2 | -$462K | |
| 3 | -$362K | |
| 4 |
MFIM
Mesirow Financial Investment Management
Chicago,
Illinois
|
-$190K |
| 5 |
Renaissance Technologies
New York
|
-$143K |